Utah Medical Products (UTMD) Shares Outstanding (Weighted Average) (2010 - 2026)

Utah Medical Products has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 3.78% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 3.78% YoY), and the FY2025 full-year result was $3.2 million, down 7.51% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $3.2 million, down from $3.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $3.7 million in Q1 2022, with the low at $3.2 million in Q1 2026.
• Average Shares Outstanding (Weighted Average) over 5 years is $3.5 million, with a median of $3.6 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) grew 0.3% in 2022 and slipped 9.3% in 2025.
• Tracing UTMD's Shares Outstanding (Weighted Average) over 5 years: stood at $3.6 million in 2022, then fell by 0.22% to $3.6 million in 2023, then fell by 3.47% to $3.5 million in 2024, then retreated by 7.51% to $3.2 million in 2025, then retreated by 1.7% to $3.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $3.2 million (Q1 2026), $3.2 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison